Mammographic density (MD) is a quantitative trait, measurable in all women, and is among the strongest markers of breast cancer risk. The population-based epidemiology of MD has revealed genetic, lifestyle and societal/environmental determinants, but studies have largely been conducted in women with similar westernized lifestyles living in countries with high breast cancer incidence rates. To benefit from the heterogeneity in risk factors and their combinations worldwide, we created an International Consortium on Mammographic Density (ICMD) to pool individual-level epidemiological and MD data from general population studies worldwide. ICMD aims to characterize determinants of MD more precisely, and to evaluate whether they are consistent across populations worldwide. We included 11755 women, from 27 studies in 22 countries, on whom individual-level risk factor data were pooled and original mammographic images were re-read for ICMD by a core team to obtain standardized comparable MD data. In the present article, we present (i) the rationale for this consortium; (ii) characteristics of the studies and women included; and (iii) study methodology to obtain comparable MD data from original re-read films. We also highlight the risk factor heterogeneity captured by such an effort and, thus, the unique insight the pooled study promises to offer through wider exposure ranges, different confounding structures and enhanced power for sub-group analyses. 
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INTRODUCTION
Since Wolfe's first studies linking mammographic parenchymal patterns to breast cancer (BC) risk in 1976, breast density -typically measured on a mammogram as mammographic density (MD) -is now recognized as one of the strongest risk factors for this malignancy [1] [2] [3] . Several features of MD make its population-level research feasible and particularly informative. MD is a continuous trait, quantifiable and, in theory, measurable in virtually all women who are eligible to receive a mammogram. High MD is associated with a large population attributable fraction for BC in high-risk countries [4] .
Several observations suggest that MD is on a causal pathway for BC, including that tumours arise within localised areas of dense tissue [5] , MD and BC have a partially shared genetic basis [6] and the effects of several risk BC factors have concordant effects on MD, and some may be mediated through MD [7, 8] . An understanding of population-level MD distributions and determinants may inform the aetiology of this common cancer in women worldwide.
Over the last 3 decades, important determinants of MD have been revealed, including genetic factors [9] and lifestyle and societal/environmental influences such as reproductive factors, alcohol intake, smoking and measures of growth and body size [7, [10] [11] [12] [13] [14] . Acquisition of this knowledge benefitted greatly from the availability of mammograms in organized BC screening programmes, but consequently the populations most studied to date have had lifestyles typical of high income countries (e.g. low parity, late age at first birth, relative young age at menarche and tall stature). Studying MD in populations with more diverse lifestyles, as can be found across countries and ethnic groups, might be more informative. This approach has already been taken in an international study of women in the US, Norway, Hawaii and Japan [15] , and in multi-ethnic studies [16] [17] [18] [19] [20] . We extended this concept by establishing an International Consortium of MD (ICMD) studies that is enriched by the inclusion of ethnic groups and countries which span the lowest to the highest BC incidence rates worldwide.
An international study of MD will shed light on the MD range at a given age, whether MD reflects an inherent feature of breast biology in all women, and the effect of a broader range of lifestyles not observable in a single population -e.g., after many pregnancies and years of breast feeding. The objectives of ICMD are thus to establish a resource platform of individual-level risk factor and standardized comparable MD data from ethnically and internationally diverse populations and use this resource to investigate the determinants of MD worldwide, whether they are consistent across countries, women and menopausal status, and whether differences in population-level MD distributions reflect differences in population-level BC incidence rates.
METHODS

Study and sample selection
The International Consortium of Mammographic Density (ICMD) is co-ordinated by the International Agency for Research on Cancer (IARC). In ICMD, we pooled individual-level MD and epidemiologic data from studies of breast cancer-free women worldwide. ICMD eligibility criteria were first applied at the study-level and then at the individual-level, as follows. Eligible studies were those of women who underwent mammography for the purpose of screening, had retrievable mammographic images in electronic format and individual-level risk factor information. Studies conducted in mammography settings that were exclusively for symptomatic disease or for women with a personal or family history of breast cancer were excluded. From within eligible studies, an individual woman was eligible for inclusion if she was 35 years or over at the time of mammography, if at least one of her mammograms was available and if, at the minimum, she had information for the calculation or estimation of age, parity and body mass index (BMI) at mammography. Women with a personal history of breast cancer were excluded.
Studies conducted in populations with diverse BC incidence rates were targeted and invited to participate in ICMD. To achieve such diversity, we included studies across all continents and multi-ethnic studies, given known geographic and ethnicity-associated variations in BC incidence rates [21] . Studies were identified through existing research networks, through consultation with collaborators in Asia, Africa and South America, and finally through internet-searches of screening programmes in areas of the world that were not already represented. In total, 27 studies contributed to ICMD, some of which included multiple ethnic groups, thus ICMD includes 40 study-and ethnicity-specific groups, hereafter referred to as "population groups". Each ICMD participating study gained local ethics approval and the overall consortium was approved by the IARC ethics committee (IEC
12-34).
Determinants of MD will initially be investigated separately in pre and postmenopausal women in each population group to examine whether associations hold across women worldwide and across major reproductive-defined periods in women's lives. To enable these investigations, we aimed to include an equal number of women (n=200), randomly selected from each stratum defined by population group and menopausal status.
This sample size of 200 was calculated in order to estimate these stratum-specific mean percent MDs within 1% at a 95% confidence level, assuming a stratum-specific standard deviation of 7% (for which n=180). An additional 20 subjects (~10% extra) was added to account for potential later exclusions (e.g. missing data, image quality poor). When selecting from organized screening program databases, we restricted ICMD inclusion to women screened within a recent time frame (dates are provided in Table 1 ).
Mammographic image: types and transfers
So as not to exclude informative populations, there was no restriction on the type of mammographic image included, i.e. we included digitized screen-film (analogue) images and digital images from both full-field digital mammography (FFDM) and computed radiography (CR, an analogue system converted to digital with laser scanner-read plates). For digital images, both "raw" (original format) and "processed" ("for presentation") formats were included. The latter is an image manipulated by manufacturer-specific algorithms to aid diagnosis. For processed images, we extracted the processing software version.
Images were anonymized prior to transfer to IARC via a secure FTP. For the most part, anonymization was carried out using NiftyView [22] , a cross platform graphical user interface provided to collaborators to remove embedded image labels and personal information from DICOM tags.
Mammographic Density Measurement
Area-based methods of MD measurement involve partitioning the total breast area into the dense area, which represents radio-dense fibro-glandular tissue, and the remaining non-dense, which reflects radiolucent adipose tissue. An example of this method is provided in Figure 1 . PMD is then calculated as 100 x dense area/total breast area. A non-trivial challenge in ICMD was to obtain comparable MD measurements across studies, given that the images types differed substantially. This task was complicated by the lack of a true gold-standard measurement method for MD [23] , and whilst existing automated methods are time-efficient and are predictive of BC risk [24] , none could be applied to all of the ICMD image types. We thus decided, a priori, to measure MD using the interactive thresholding method Cumulus (Dr Martin Yaffe, Sunnybrook Health Sciences Centre, Toronto), which can be applied to all DICOM images. Cumulus-measured MD has consistently shown strong associations with BC risk [25] . Cumulus version 6 was applied, which performs automatic breast edge delimitation, whilst the user delimits other non-breast areas manually and sets the greyscale level to dichotomize dense from non-dense greyscale levels ( Figure 1 ). We did not choose a categorical classification of MD as it would have less statistical power in analysing this quantitative trait. To aid reading, 8-bit digitized images were converted to 16-bit prior to reading and raw digital images were inverse log transformed.
MD reading protocol
Whilst Cumulus-based MD readings tend to have high repeatability for a given reader, readings are reader-specific [26] thus to achieve comparability of MD readings across studies we conducted centralized readings by a small team of experienced readers (VM, NB, IS) using a protocol designed to ensure no association between study and reader.
Studies with the same image type (digitized analogue, processed digital or raw digital) were grouped (3 to 7 studies per group) and within each group, images were randomly allocated to batches of approximately 90 (plus repeats, see following section), which were then divided evenly between readers. One image per woman was read and readers were blinded to all personal and study information. View, but not laterality, affects measured MD [27] , thus if multiple views were available, we preferentially read the more widely available left medio-lateral oblique (MLO), right-MLO, left cranio-caudal (CC) then right-CC.
Within-reader measurement errors in MD were assessed by re-reading 3 randomly selected images within each reading batch, and between-reader differences by re-reading 5 randomly selected images from each batch by the other 2 readers. Additionally two batches (at the start and towards the end) were read by all 3 readers. A total of 13575 readings were completed over an 8 month period across 146 reading batches. The only exception to this is the Canadian images which could not be transferred internationally, so they were read by a single reader. During the MD assessment process, readers noted features that may impact on the MD measurement.
Absolute breast and dense areas in number of pixels were converted to cm 2 using the pixel size information, which was extracted from DICOM tags or obtained from collaborators (Suppl. Table 1 ). For one study (US-USC), this information was not available for 78 of 444 images, so these images will be included in PMD but not absolute area-based analyses.
Risk factor data and its harmonization
Minimal risk factor data required for inclusion were age, height, weight and parity.
The first three variables were inclusion criteria as age and BMI (calculated as weight/height 2 in kg/m 2 ) are both strongly inversely related to MD, yet positively associated with postmenopausal BC risk, thus the pertinent BC risk factor is percent MD (PMD) or dense area for a woman's age and BMI [28] . The timing of height and weight ascertainment,
ideally, but not always, at the time of mammography, was obtained. In addition to these variables, we requested woman-level information on reason for mammography, ethnicity, age at menarche, age at first birth, age at last birth, breast feeding durations, use of exogenous hormones (i.e. oral contraceptives and hormone therapy), age at menopause, reason for menopause, personal cancer history, personal history of breast problems, family history of breast cancer, tobacco and alcohol consumption and indicators of socioeconomic status. We requested each variable in its original, most basic format and their definitions.
To date, the key variables from study-specific datasets have been merged into a single harmonized core dataset. Where definitions of a variable varied between studies (for example parity could be defined as the total number of children, number of live births, number of full term births,) the definitions were also imported. Continuous variables were converted to a common unit of measurement. Some studies collected continuous variables in categories (for example, age at first birth). The categorical variable was imported into the main dataset as a separate variable and the estimated median of that category pooled with the continuous data from other studies. For Figure 4 the categories of age at first birth and age at menarche were derived from the continuous variable in the main study dataset, therefore for some studies this was the median of the category; study-level definitions for age at first birth and parity are shown in Supplemental Table 2 . ). Whilst the original random selection of women from each menopausal group was based on study-specific definitions of menopause, those definitions were also individually obtained and will be presented in future menopause-focussed investigations.
Data were checked for consistency and implausible values checked. For the core data, adult heights less than 1.0 m or over 2.1 m, or with a BMI less than 12 kg/m 2 or greater than 80 kg/m 2 , were excluded. As the available data on complex lifestyle variables such as contraceptive use, hormone therapy, smoking and alcohol use, varied substantially between studies, to begin with, these data were pooled into the core dataset into simplified variables stating if the participant is a current, past, ever or never user. For future analyses focusing on these variables, more complex data will be re-extracted from the original datasets, and their definitions and distributions presented at that point.
RESULTS and DISCUSSION
Studies included: countries and screening settings
ICMD includes 11755 women from 27 studies across 22 countries. The countries and their BC incidence rates are provided in Figure 2 . All world regions are included, as are countries with 4-fold differences in BC incidence rates, e.g. from ~25/100,000 in India and Iran, to over 90 in the UK and US. The consortium includes less or never-studied countries in terms of MD, notably South Africa, Kenya, Turkey, Iran and India. Most studies were in a restricted geographical region of the country, as indicated in Table 1. The table also provides further details of study populations. Hereafter, studies will primarily be referred to by their country name, with the exception of the multiple studies in the UK and US. Multiple ethnic groups were included in the studies from Israel (Jewish and Arab), the UK (White, Black, and Asian women), the US (White, Black, Asian and Native Hawaiian), Singapore and Malaysia (Malay, Chinese and Indian) and Australia (by country of birth; Australia, Greece and Italy).
Amongst the studies included, mammograms were taken in various settings. Over half (54%) of ICMD women were screened in organized screening programs (i.e., invitation to screening was sent to all women in a defined population) or in the US where screening coverage rates are similar to those of organised screening programs. The 13 studies were in Israel, The Netherlands, Norway, Spain, Canada, Australia, Japan, the US and all but one of the UK studies. For some of these studies risk factors data had been collected as part of larger cohorts (US Multiethnic Cohort study, the US Nurses' Health Study (NHS) and NHS II, A challenge in ICMD was to find low-risk settings in which women representative of the general population had or were undergoing mammographic screening. The remaining 8% of ICMD women, from 3 studies, were from such settings. Mammography was part of ad hoc community outreach trials e.g., one-off screening initiatives, where, with the addition of an interviewer-administered questionnaire at mammography, relevant data were or would be available. The settings were as follows: in India, free mammography was provided to women in a rural community during March 2008; in Nairobi, Kenya, the Aga Khan Hospital provides low-cost mammography during breast cancer awareness month (October 2013) and during visits thereafter until December 2013 women were invited to complete the questionnaire; and in South Africa, when the Pink Drive's mobile mammography van was providing free community screening in Soweto in 2014, women were invited to take part in an interviewer-administered two-page questionnaire.
Mammographic images
A summary of image types included is provided in Table 2 (and study-specific details in Suppl. Table 1 ). In all, 51.1% of images were digitized screen-film images and the remaining images were digital images, of which 9.0% were captured on CR and 91.0% on FFDM systems. Machines used in multiple studies include models of the GE Senograph, Hologic Lorad Selenia and Siemens Mammomat (Table 2 and Suppl. Table 1 ). Of the digital images, 91.3% were in processed formats and 8.7% were in the original 'raw' format.
The vast majority (94.5%) of images were considered of acceptable quality, whilst only 2.3% were considered suboptimal (due to low resolution, image errors or artefacts) and were excluded ( Table 2 ). The main issues with the few remaining images were poor skin visibility and truncation of the breast. Where the skin was not visible (1.6% of images), only the dense area could be estimated and not total breast area or PMD. Where the skin was 'barely visible' (0.3% of images) estimates of dense area, total area and PMD were included in the main analyses, but will be excluded in sensitivity analyses. This mainly occurred in digitised analogue films, perhaps due to a suboptimal optical range of the digitizer.
Truncated images (0.9%) were often due to the breast being too large for the plate used.
For these images, if multiple images were taken, they were viewed simultaneously and the image encompassing the greater proportion of the breast was read using an estimated enlarged breast area to account for the area off the film.
The overall PMD distributions across women in ICMD are shown in Figure 3A, illustrating the PMD range from 0 to 80%. Within-reader SDs were much smaller than between-woman SDs ( Figure 3B ), thus each reader had an intra-class correlation over 90%.
By design, between-study differences will not be due to reader differences, however the reader-specific distributions had different degrees of right skewness (skewness parameters by reader are 0.42, 0.81 and 1.02), thus transformations were needed before linear regression (i.e. normal-errors) modelling of PMD or of dense-area could be performed. To achieve this, we first corrected for batch-drift across each reader's readings by fitting a quadratic association of PMD on batch order and predicting batch-corrected PMD as PMD in the absence of batch drift as per PMD readings for the batch range where drift was absent.
Thereafter, square-root transformations were taken of dense area, breast area and PMD, to achieve normally distributed outcomes for normal-errors regression models. This transformation has been frequently used for area-based MD measures [30] ; square-root dense area represents the radius of a circle defining the dense area, or the length of the side of a square with dense area.
Risk factors: Lifestyle heterogeneity captured
Risk factor information was typically collected by questionnaire at or around mammography, with the exception of five studies (table 1) , for which explanatory data were collected at least 2 years before or several years after mammography. Menopausal status was ascertained at the individual level in all but one study. Height and weight were measured in 18 of the 27 studies and self-reported by women in the remaining studies.
Anthropometrics were measured in two-thirds of studies and self-reported in the remaining;
in most studies they were recorded at the time of mammography ( Table 1 ). The remaining key variables (age at first birth, age at first menstruation and parity) were self-reported in all studies.
Median age at mammography was 52 years (90% range 39-66 years) across studies;
there were over 2000 women in each age interval: 35-44, 45-49, 50-54, 55-59 and 60+ years.
Most studies span this age range, with the exception of Chile and the UK-Age Trial, which by their original study design only included younger populations and studies set in screening programs with older recommended screening ages. The wide age range will enable finer analyses by age and menopausal status than previously possible.
A flavour of the immense heterogeneity of lifestyles captured in ICMD is shown in The reproductive factors shown in figures 4B-4D are, for the most part, as expected, with profiles associated with higher BC risk being more prevalent in higher income countries -including earlier menarche, later age at first birth and lower parity -and the reverse was seen in transitional countries. However, on closer examination, the risk factor combinations in ICMD displayed more complexity, which can be illustrated by comparing women from South Africa, Iran and Israel (Arab sub-group). All three groups had amongst the highest mean BMIs (Fig. 4A) , consistent with the high obesity prevalence in those transitional or post-transitional countries [31] [32] [33] . These three groups of women also had a relatively young age at first birth, with approximately 70% having had their first child by 23 years of age (Fig. 4B ) -a percentage nearly double that in ICMD groups from Europe and the US.
However, these 3 groups differed considerably in terms of age at menarche and parity -the Israel Arab group of women had a mean age at menarche (12.8 years), i.e., over 2 years earlier than their South Africa counterparts (14.9 years). This large difference in means is comparable to the size of the secular trends in menarche that occurred over nearly 80 years in the UK or US [34, 35] . Parity also differed between these groups; whereas the parity of South African women is relatively low (median 2-3), 30% of Iranian and 60% of Israeli Arab women in ICMD had at least 6 births. These differences are consistent with the timing of the fertility transitions, which, although rapid, occurred much later in Iran than in South Africa [36, 37] . The ICMD pooled data also included many women with very high parity (over 700 women with 6 or more births), which will enable an examination of the effect of repeated pregnancies on breast composition.
Such heterogeneity is present in several other risk factors, including breastfeeding, alcohol intake and smoking habits and will greatly enable the assessment of their influence associations with MD.
Challenges and limitations
A large-scale pooling project such as ICMD, whilst statistically powerful, is not without considerable challenges and limitations. First, concerning the representativeness of included women, the diversity of screening settings (none of which have complete population coverage) will impact on who the ICMD study sample represents -be it the general population in the relevant geographical area or a more restricted subset of this population. For analyses of the determinants of MD, the generalisability of the MD distribution itself to that of a larger study population is not of primary concern, rather it is whether risk factor-MD associations observed in ICMD are generalizable to the general population. In this respect, ICMD study samples that originate from specific occupations (e.g. the NHS and the Polish study) or from more affluent or more educated sectors of the population can contribute valuably and validly. However, for the investigation of whether population-level MD distributions reflect population-level differences in breast cancer incidence rates, findings will only be valid if the comparisons of the same underlying populations are made. For this component, it should be emphasized that breast cancer incidence rates are not estimated from a follow-up of women in ICMD, rather they will be obtained from external population-level estimates from cancer registries covering the same or similar catchment population. In many settings, screening attendees are more likely to be of higher socioeconomic status/educational level and would thus have higher BC incidence rates. Such biases are likely to affect studies to greater or lesser degrees depending on the screening features, e.g. cost involved, extent of catchment population, how women are invited or how screening is advertised. In particular, the study samples from short-term once-off screening in Kenya and from opportunistic screening programs may have an overrepresentation of more educated women who had to pay for the transport to reach the hospital and the fees, albeit reduced, for mammography. The community-level free screening in Soweto, South Africa, may have a higher proportion of women with previous breast problems, a family history of disease or symptomatic disease.
Second, a further challenge is to create meaningful harmonized risk factor data.
Their harmonized data may lose precision by collapsing data into simplified variables, but analyses will also be conducted on smaller subsets with exposures pooled in finer detail.
Socioeconomic data do not have the same discriminatory ability or meanings in different settings, so within-study categories will be the basis of this exposure.
Finally, the greatest challenge in ICMD is to achieve comparable MD data. Whilst the reading protocol should remove reader-effects, image types vary between studies, and a whole study's MD readings may be shifted up or down according to the particular system's processing algorithm and the reader's interpretation of the threshold cut-point in images displayed in raw or in processed formats. Indeed, systematic differences in dense area, breast area and in PMD are known to arise from the type of image, e.g. due to processing or differential compression [38] . The likely influence on MD needs to be considered as films from most studies were of a single image type and could thus act as a strong confounder.
Further, analogue films originated predominantly from high-risk populations where screening occurred in earlier years, as long as 30 years ago, whereas recent films from lower-risk populations were more likely to be digital. Two analytical approaches will be taken in an attempt to overcome the potential influence of processing algorithms on MD: (i) analyses will first be conducted at the study-level and study-specific effects combined using meta-analytic approaches, so that there is no variation in image type within each analysis and thus no confounding by image type; (ii) for analyses of the full ICMD dataset within the same statistical model, MD values (PMD and dense area) will first be corrected for the influence of the image type and processing algorithm. The calibration correction factors will be derived from sets of paired digital images that have been stored in both raw and processed images (from 2 FFDM and 1 CR system). These results will be presented in a separate article.
Summary
ICMD has assembled a rich international resource of individual-level epidemiologic and MD information allowing the study of the epidemiology of MD. The risk factor heterogeneity captured is extensive and will help elucidate influences on the natural history of the breast's fibro-glandular composition. Population shifts in MD distributions are relevant for population strategies of disease prevention and require the understanding of the determinants of population means, for which ICMD will provide a valuable contribution. 
